MindWalk Files European Patent for 600M-Record Bio-AI Data Architecture
RXRX•MindWalk Holdings filed a foundational European patent application (EP26187897.9) covering its multi-dimensional data architecture powering HYFT® Technology, claiming a database of over 600 million hyperdimensional vector records. Recursion Pharmaceuticals was listed among competitors shifting competitive advantage from AI models to proprietary biological data layers.
1. Patent Filing Details
MindWalk Holdings submitted European Patent Office application EP26187897.9, detailing a hyperdimensional vector data structure that encodes biological subsequences with at least 50 heterogeneous properties per record. The filing describes a database of over 600 million such records and a method for vector-space operations to infer biological properties without relying on sequence alignment or a specific AI model.
2. Competitive Context
The company positions this patent as a move to protect the data layer underpinning its HYFT® Technology, arguing that proprietary structured data offers a more durable advantage than interchangeable AI models. Recursion Pharmaceuticals, along with AbCellera, Schrödinger and Tempus AI, is cited as part of a cohort of life-sciences AI firms shifting focus to domain-specific data architectures.
